0000895345-21-000988.txt : 20211124
0000895345-21-000988.hdr.sgml : 20211124
20211124210727
ACCESSION NUMBER: 0000895345-21-000988
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211123
FILED AS OF DATE: 20211124
DATE AS OF CHANGE: 20211124
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BERNSTEIN JEFFREY DANIEL
CENTRAL INDEX KEY: 0001859499
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40365
FILM NUMBER: 211448924
MAIL ADDRESS:
STREET 1: 200 WEST STREET
CITY: NEW YORK
STATE: NY
ZIP: 10282
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Privia Health Group, Inc.
CENTRAL INDEX KEY: 0001759655
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 950 N. GLEBE RD., SUITE 700
CITY: ARLINGTON
STATE: VA
ZIP: 22203
BUSINESS PHONE: 571-366-8850
MAIL ADDRESS:
STREET 1: 950 N. GLEBE RD., SUITE 700
CITY: ARLINGTON
STATE: VA
ZIP: 22203
FORMER COMPANY:
FORMER CONFORMED NAME: PH Group Parent Corp.
DATE OF NAME CHANGE: 20181120
4
1
form4.xml
X0306
4
2021-11-23
0001759655
Privia Health Group, Inc.
PRVA
0001859499
BERNSTEIN JEFFREY DANIEL
200 WEST STREET
NEW YORK
NY
10282
true
Common Stock
2021-11-23
4
S
0
2505732
27.695
D
28676936
I
See footnotes
The Reporting Person is a managing director of Goldman Sachs & Co. LLC ("Goldman Sachs"). Goldman Sachs is a subsidiary of The Goldman Sachs Group, Inc. ("GS Group"). The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein, if any.
On May 11, 2021, Brighton Health Group Holdings, LLC made a pro rata distribution of 79,178,464 shares of common stock, par value $0.01 per share (the "Common Stock") of the Issuer to its members, including an aggregate 30,512,093 shares of Common Stock to the GS Funds (as defined below).
Pursuant to an underwriting agreement, dated November 18, 2021 (the "Underwriting Agreement"), the GS Funds (as defined below) offered and sold an aggregate 2,505,732 shares of Common Stock as set forth in the final prospectus filed by the Issuer on November 22, 2021, which offering was consummated on November 23, 2021 (the "Offering"). The amount above represents the $29.00 public offering price per share of Common Stock in the Offering less the underwriting discount of $1.305 per share of Common Stock.
As of November 22, 2021, as a result of the Offering, GS Group and Goldman Sachs may be deemed to beneficially own indirectly 28,006,361 shares of Common Stock by reason of Common Stock held by certain investment entities (the "GS Funds") of which Goldman Sachs and GS Group are the general partner, managing limited partner, managing general partner, managing partner, managing member or member.
/s/ Crystal Orgill, attorney-in-fact
2021-11-24